Pulmonary embolism and deep vein thrombosis related to oral contraceptive use

Pulmonary embolism and deep vein thrombosis related to oral contraceptive use

초록

Pulmonary embolism (PE) and deep vein thrombosis (DVT) is a serious medical problem causing considerable morbidity and mortality. Risk factors of thrombosis are surgery, trauma, pregnancy, tumor, oral contraceptive as well as genetic risk factors though genetic risk factors were found in about 5% to 10% of cases. Yasmin, a combined oral contraceptive containing ethinylestradiol 30 μg and drospirenon 3 mg was launched in the United Kingdom in 2002. We had experienced a patient, 24-year-old young woman with left inguinal pain on ambulation, and edema of left leg four months after taking Yasmin. We performed chest pulmonary angiography computed tomography (CT) and lower extremity venogram CT. She was diagnosed to PE in both lower lobes and DVT below the level of left external iliac vein, and treated by low molecular weight heparin and warfarin. We report this case with brief review of literatures.

키워드

Deep vein thrombosis; Oral contraceptive; Pulmonary embolism
제목
Pulmonary embolism and deep vein thrombosis related to oral contraceptive use
제목 (타언어)
Pulmonary embolism and deep vein thrombosis related to oral contraceptive use
저자
김지영; 김윤숙
DOI
10.5468/ogs.2013.56.4.273
발행일
2013
저널명
Obstetrics & Gynecology Science
권
56
호
04
페이지
273 ~ 276